scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.EXGER.2013.02.020 |
P8608 | Fatcat ID | release_yy2k6ecx3fas5clcbeefa3rjla |
P698 | PubMed publication ID | 23485446 |
P2093 | author name string | Huai-Rong Luo | |
Qin-Li Wan | |||
Gui-Sheng Wu | |||
Shan-Qing Zheng | |||
P433 | issue | 5 | |
P921 | main subject | lifetime | Q22675021 |
aspirin | Q18216 | ||
Caenorhabditis elegans | Q91703 | ||
P304 | page(s) | 499-506 | |
P577 | publication date | 2013-02-26 | |
P1433 | published in | Experimental Gerontology | Q15766996 |
P1476 | title | Aspirin extends the lifespan of Caenorhabditis elegans via AMPK and DAF-16/FOXO in dietary restriction pathway | |
P478 | volume | 48 |
Q38998415 | AMPK as a Pro-longevity Target. |
Q34871517 | AMPK at the nexus of energetics and aging. |
Q89012047 | Aspirin Derivative 5-(Bis(3-methylbut-2-enyl)amino)-2-hydroxybenzoic Acid Improves Thermotolerance via Stress Response Proteins in Caenorhabditis elegans |
Q41072898 | Aspirin increases metabolism through germline signalling to extend the lifespan of Caenorhabditis elegans |
Q47878038 | Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein Aggregation. |
Q51663636 | Chlorogenic Acid Extends the Lifespan of Caenorhabditis elegans via Insulin/IGF-1 Signaling Pathway. |
Q39343002 | Current Perspective in the Discovery of Anti-aging Agents from Natural Products |
Q39420265 | Experimental models for aging and their potential for novel drug discovery. |
Q33829205 | From rapalogs to anti-aging formula |
Q55378545 | Impact of Aspirin Eugenol Ester on Cyclooxygenase-1, Cyclooxygenase-2, C-Reactive Protein, Prothrombin and Arachidonate 5-Lipoxygenase in Healthy Rats. |
Q26538688 | Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects |
Q35243878 | Impacts of metformin and aspirin on life history features and longevity of crickets: trade-offs versus cost-free life extension? |
Q92838065 | In silico clinical trials for anti-aging therapies |
Q35189284 | In vivo and in vitro metabolism of aspirin eugenol ester in dog by liquid chromatography tandem mass spectrometry |
Q92978875 | Intermediate metabolites of the pyrimidine metabolism pathway extend the lifespan of C. elegans through regulating reproductive signals |
Q36292001 | Koschei the immortal and anti-aging drugs |
Q38659532 | Novel strategies for anti-aging drug discovery |
Q39088167 | Plant-parasitic nematodes: towards understanding molecular players in stress responses |
Q28546664 | Preventive Effect of Aspirin Eugenol Ester on Thrombosis in κ-Carrageenan-Induced Rat Tail Thrombosis Model |
Q28818367 | Screening lifespan-extending drugs in Caenorhabditis elegans via label propagation on drug-protein networks |
Q37322080 | Strategies and Challenges in Clinical Trials Targeting Human Aging |
Q43223569 | The Lifespan-Promoting Effect of Otophylloside B in Caenorhabditis elegans |
Q60358611 | The Way Forward: Translation |
Q95936711 | The quest to slow ageing through drug discovery |
Q94528642 | Translational Geroscience: From invertebrate models to companion animal and human interventions |
Q90854384 | Turning back time with emerging rejuvenation strategies |
Q89780143 | Uric acid induces stress resistance and extends the life span through activating the stress response factor DAF-16/FOXO and SKN-1/NRF2 |
Q36442945 | When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow? |
Search more.